Literature DB >> 22346397

Centralization of a regional clinical microbiology service: The Calgary experience.

D L Church1, P Hall.   

Abstract

Diagnostic laboratory services in Alberta have been dramatically restructured over the past five years. In 1994, Alberta Health embarked on an aggressive laboratory restructuring that cut back approximately 30% of the overall monies previously paid to the laboratory service sector in Calgary. A unique service delivery model consolidated all institutional and community-based diagnostic testing in a company called Calgary Laboratory Services (CLS) in late 1996. CLS was formed by a public/private partnership between the Calgary Regional Health Care Authority (CRHA) and MDS-Kasper Laboratories. By virtue of its customer service base and scope of testing, CLS provides comprehensive regional laboratory services to the entire populace. Regional microbiology services within CLS have been successfully consolidated over the past three years into a centralized high volume laboratory (HVL). Because the HVL is not located in a hospital, rapid response laboratories (RRLs) are operated at each acute care site. Although the initial principle behind the proposed test menus for the RRLs was that only procedures requiring a clinical turnaround time of more than 2 h stay on-site, many other principles had to be used to develop and implement an efficient and clinically relevant RRL model for microbiology. From these guiding principles, a detailed assessment of the needs of each institution and extensive networking with user groups, the functions of the microbiology RRLs were established and a detailed implementation plan drawn up. The experience at CLS with regards to restructuring a regional microbiology service is described herein. A post-hoc analysis provides the pros and cons of directing and operating a regionalized microbiology service.

Entities:  

Keywords:  Microbiology; Regional centralization; Restructuring

Year:  1999        PMID: 22346397      PMCID: PMC3250725          DOI: 10.1155/1999/372382

Source DB:  PubMed          Journal:  Can J Infect Dis        ISSN: 1180-2332


  4 in total

1.  Use of telepathology for routine surgical pathology review in a test bed in the Department of Veterans Affairs.

Authors:  B E Dunn; U A Almagro; H Choi; D L Recla; R S Weinstein
Journal:  Telemed J       Date:  1997

2.  On the definition and evaluation of telemedicine.

Authors:  R L Bashshur
Journal:  Telemed J       Date:  1995

Review 3.  Telemedicine: where it is and where it's going.

Authors:  J Grigsby; J H Sanders
Journal:  Ann Intern Med       Date:  1998-07-15       Impact factor: 25.391

4.  Telemedicine technology and clinical applications.

Authors:  D A Perednia; A Allen
Journal:  JAMA       Date:  1995-02-08       Impact factor: 56.272

  4 in total
  8 in total

1.  Quantitative gram stain interpretation criteria used by microbiology laboratories in Alberta, Canada.

Authors:  D Church; E Melnyk; B Unger
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

2.  Recovery of Gram-negative bacilli in stored endotracheal aspirates.

Authors:  Tarah D Ranke; Paula Strassle; Anthony D Harris; Jingkun Zhu; J Kristie Johnson
Journal:  J Clin Microbiol       Date:  2012-05-30       Impact factor: 5.948

3.  Evaluation of BBL CHROMagar O157 versus sorbitol-MacConkey medium for routine detection of Escherichia coli O157 in a centralized regional clinical microbiology laboratory.

Authors:  D L Church; D Emshey; H Semeniuk; T Lloyd; J D Pitout
Journal:  J Clin Microbiol       Date:  2007-07-18       Impact factor: 5.948

Review 4.  Consolidation of Clinical Microbiology Laboratories and Introduction of Transformative Technologies.

Authors:  Zisis Kozlakidis; Alex van Belkum; Olivier Vandenberg; Géraldine Durand; Marie Hallin; Andreas Diefenbach; Vanya Gant; Patrick Murray
Journal:  Clin Microbiol Rev       Date:  2020-02-26       Impact factor: 26.132

5.  One-year mortality of bloodstream infection-associated sepsis and septic shock among patients presenting to a regional critical care system.

Authors:  Kevin B Laupland; David A Zygun; Christopher J Doig; Sean M Bagshaw; Lawrence W Svenson; Gordon H Fick
Journal:  Intensive Care Med       Date:  2005-01-22       Impact factor: 17.440

6.  Blood cultures in ambulatory outpatients.

Authors:  Kevin B Laupland; Deirdre L Church; Daniel B Gregson
Journal:  BMC Infect Dis       Date:  2005-05-17       Impact factor: 3.090

7.  Population-based laboratory surveillance for Giardia sp. and Cryptosporidium sp. infections in a large Canadian health region.

Authors:  Kevin B Laupland; Deirdre L Church
Journal:  BMC Infect Dis       Date:  2005-09-16       Impact factor: 3.090

8.  The Validation of a Novel Surveillance System for Monitoring Bloodstream Infections in the Calgary Zone.

Authors:  Jenine R Leal; Daniel B Gregson; Deirdre L Church; Elizabeth A Henderson; Terry Ross; Kevin B Laupland
Journal:  Can J Infect Dis Med Microbiol       Date:  2016-06-07       Impact factor: 2.471

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.